Jingmian Zhang

发表

Preclinical evaluation of 99mTc direct labeling ZHER2:V2 for HER2 positive tumors imaging.

Yang Yang, Xinming Zhao, Yu-ying Xing, 2018, Oncology letters.

Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer

Xinming Zhao, Jingmian Zhang, Jian-fang Wang, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Therapeutic efficacy and imaging assessment of the HER2-targeting chemotherapy drug ZHER2:V2-pemetrexed in lung adenocarcinoma Xenografts

Xinming Zhao, Jingmian Zhang, Jian-fang Wang, 2019, Investigational New Drugs.

68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2022, Medicine.

Value of Presurgical 18F-FDG PET/CT Radiomics for Predicting Mediastinal Lymph Node Metastasis in Patients with Lung Adenocarcinoma.

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2022, Cancer biotherapy & radiopharmaceuticals.

Developing a clinical and PET/CT volumetric prognostic index for risk assessment and management of NSCLC patients after initial therapy.

James X Zhang, D. Appelbaum, Y. Pu, 2022, Frontiers in bioscience.

Case Report: 68Ga-FAPI PET/CT, a more advantageous detection mean of gastric, peritoneal, and ovarian metastases from breast cancer

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2022, Frontiers in Oncology.

(99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma.

Fan Wang, C. Ding, Xinming Zhao, 2016, Cancer biotherapy & radiopharmaceuticals.

Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).

Xinming Zhao, Jingmian Zhang, Jingya Han, 2015, Nuclear medicine and biology.

18F-labeled FGFR1 peptide: a new PET probe for subtype FGFR1 receptor imaging

Xinming Zhao, Jingmian Zhang, Jingya Han, 2023, Frontiers in Oncology.

Predicting PD-L1 expression status in patients with non-small cell lung cancer using [18F]FDG PET/CT radiomics

Xinming Zhao, Jingmian Zhang, Lihua Liu, 2023, EJNMMI Research.

Value of pre-treatment 18F-FDG PET/CT radiomics in predicting the prognosis of stage III-IV colorectal cancer

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2023, European journal of radiology open.

Pre-Clinical Study of the [18F]AlF-Labeled HER2 Affibody for Non-Invasive HER2 Detection in Gastric Cancer

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2022, Frontiers in Medicine.

Bombesin ligand functionalized gold nanoparticles containing five different linker moieties for pancreatic tumor targeting

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2014 .

Preparation and Evaluation of 99mTc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2014, The Journal of Nuclear Medicine.

in Malignant Tumors ( EGFR )-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression Tc-Epidermal Growth Factor Receptor 99 mPreparation and Evaluation

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2014 .

In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model.

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2019, Nuclear medicine and biology.

Feasibility of One-Day PET/CT Scanning Protocol with 68Ga-DOTA-FAPI-04 and 18F-FDG for the Detection of Ovarian Cancer Recurrence and Metastasis.

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2023, Cancer biotherapy & radiopharmaceuticals.

Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2023, EJNMMI Research.

Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [68Ga]Ga-DOTA-FGFR1-Peptide.

Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, 2024, Cancer biotherapy & radiopharmaceuticals.